Dmitry Karshtedt

Dmitry Karshtedt
Title:
Associate Professor of Law
Address:
2000 H Street, NW
Washington, District Of Columbia 20052
Phone:
202-994-5725
Email:
[email protected]

Dmitry Karshtedt's primary research interest is in patent law. His legal scholarship has been published in the Iowa Law Review, Vanderbilt Law Review, and Harvard Journal of Law & Technology, among other outlets, and cited in three of the leading patent law casebooks, a casebook on intellectual property, and several treatises. Professor Karshtedt's academic work has won several awards, including the Samsung-Stanford Patent Prize and the scholarship grant for judicial clerks sponsored by the University of Houston Law Center Institute for Intellectual Property and Information Law.

Before going into law, Professor Karshtedt completed a Ph.D. in chemistry from U.C. Berkeley and worked as a staff scientist for a semiconductor materials startup. He is a co-author on five scientific publications and a co-inventor on twelve U.S. patents. Professor Karshtedt received his law degree from Stanford Law School, where he served as the Senior Symposium Editor for the Stanford Law Review. Professor Karshtedt practiced in the Patent Counseling and Innovation Group at Wilson Sonsini Goodrich & Rosati and clerked for the Honorable Kimberly A. Moore on the U.S. Court of Appeals for the Federal Circuit. Immediately prior to starting his position at GW, Professor Karshtedt was a Fellow at the Center for Law and the Biosciences at Stanford Law School.

Curriculum Vitae     Publications

Education

AB, Harvard University; PhD, UC Berkeley; JD, Stanford University

In the News

"Fed. Cir. Limits Review of Serial Patent Challenges"

September 29, 2021
Dmitry Karshtedt is quoted by Bloomberg Law about a federal circuit court ruling that determined the U.S. Patent and Trademark Office abused its discretion during patent review.

"Teva ‘Skinny Label’ Ruling Comes Amid Lawmaker Drug Cost Fight"

August 06, 2021

Dmitry Karshtedt is quoted by Bloomberg Law following a federal appeals court decision on a generic drug patent infringement case.

"Cost-cutting generics and biosimilars stuck in legal limbo"

July 21, 2021
Dmitry Karshtedt is quoted in MedCity News about legal roadblocks facing generic pharmaceutical manufacturers amid high drug prices.

"Patent Owners Are Throwing In the Towel on Arthrex - With a Couple Exceptions"

July 08, 2021

Dmitry Karshtedt is quoted by Law.com about patent owners pushing back against an Appointment Clause violation remedy created by the Supreme Court.

"PTAB Judges' Bonus Structure Draws Scrutiny In New Report"

June 23, 2021

Dmitry Karshtedt is quoted in Law360 about a SCOTUS decision that gives the USPTO director authority to reverse rulings by PTAB judges.